Sudeep Pharma Limited, a active public limited company, was established on 21 December 1989 in Baroda, Gujarat, India. Engaging in preventive health supplements within the manufacturing sector, it holds CIN: U24231GJ1989PTC013141. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹11.13 Cr.
Formerly known as Sudeep Pharma Limited. It upholds a compliant status. Employing 377 professional, Its leadership includes Reshma Suresh Patel (Director), Raghunandan Sathyanarayan Rao (Director), Sujit Jaysukh Bhayani (Managing Director). Past directors included Reshma Suresh Patel, Rajendra Chunibhai Patel, Vishal Rakesh Agrawal. It holds ₹146.50 Cr open charges and ₹81.90 Cr settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at 129/1/A, G.I.D.C. Estate Nandesari, Baroda, Gujarat, 391340.
U24231GJ1989PLC013141
013141
21 December 1989
₹15.00 Cr
₹11.13 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Sudeep Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Reshma Suresh Patel | Director | 13 Sep 2024 | Current |
| Raghunandan Sathyanarayan Rao | Director | 13 Sep 2024 | Current |
| Sujit Jaysukh Bhayani | Managing Director | 01 Mar 1995 | Current |
| Ajay Shrirang Kandelkar | Whole-Time Director | 13 Sep 2024 | Current |
| Shanil Sujit Bhayani | Whole-Time Director | 10 Dec 2021 | Current |
| Samaresh Parida | Director | 13 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Oct 2024 | Past |
| Pramod Abcsdd | Director | 26 Oct 2015 | Past |
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Director | 01 Feb 2009 | Past |
| Pramod Abcsdd | Additional Director | 25 Oct 2024 | Past |
| Pramod Abcsdd | Director | 31 Mar 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sudeep Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.33% increase. The company also saw a substantial improvement in profitability, with a 49.5% increase in profit. The company's net worth Soared by an impressive increase of 45.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sudeep Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,465,000,000.00
₹818,976,375.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2024 | Others | ₹75.00 Cr | Open |
| 29 Sep 2020 | Citi Bank N.A. | ₹20.00 Cr | Open |
| 20 Aug 2019 | Citi Bank N.A. | ₹6.50 Cr | Open |
| 27 Jan 2014 | Citi Bank N.A. | ₹45.00 Cr | Open |
| 29 Jan 2022 | Others | ₹60.69 Cr | Satisfied |
Explore comprehensive loan charge details -
Sudeep Pharma has a workforce of 377 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sudeep Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudeep Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sudeep Pharma Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was documented.
The activity Sudeep Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
A charge with Others of Rs. 75.00 Cr registered on 30 Dec 2024 with Charge ID 101026268 was modified on 28 Feb 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101026268 was registered on 30 Dec 2024. was completed.
Progress on Dimple Ashwinbhai Mehta was appointed as a Company Secretary was appointed as a Company Secretary on 13 Dec 2024 & has been associated with this company since 11 months 15 days . was documented.
A charge registered on 29 Jan 2022 via Charge ID 100539717 with Others was fully satisfied on 12 Dec 2024. was recorded as a recent event.
Gadchiroli Zilla Parishad partners with pharmaceutical giant Sun Pharma to eliminate malaria through a public-private partnership. The project aims to control and eventually eradicate malaria in endemic zones..
The CIN of Sudeep Pharma Limited is U24231GJ1989PLC013141.
Sudeep Pharma Limited is headquartered at 129/1/A, G.I.D.C. Estate Nandesari, Baroda, Gujarat, 391340.
Sudeep Pharma Limited was incorporated on 21 December 1989.
The current directors of Sudeep Pharma Limited are
The primary industry of Sudeep Pharma Limited is Manufacturing.
Sudeep Pharma Limited is unlisted.
The authorized capital of Sudeep Pharma Limited is ₹15.00 Cr, and the paid-up capital is ₹11.13 Cr.
The compliance status of Sudeep Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX